Stocks & Options
Trading Strategies
Institutional Ownership
SEC Filings TLDR
Analysis Reports
AI Tools
EN
Sign in
Vivos Therapeutics, Inc. Reports FY 2025 Financial Results
2026-04-15
SEC Filing 10-K
(0001493152-26-016854)
Please check the link below for details.
Ticker mentioned:
VVOS
Source:
Original SEC Document β